Novartis Investigative Site

High Heaton, Newcastle Upon Tyne NE7 7DN

0 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumors, Basal Cell Carcinoma, Idiopathic Pulmonary Fibrosis, Metastatic Breast Cancer, Metastatic Renal Cell Carcinoma, Non-alcoholic Steatohepatitis (NASH), Non-small Cell Lung Cancer

Studies at this site

• Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects — Stopped early
• Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis — Stopped early
• Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis — Completed
• Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors — Completed
• A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma — Completed